Searchable abstracts of presentations at key conferences in endocrinology

ea0005p213 | Reproduction | BES2003

Testosterone pellet implants - an acceptable mode of androgen replacement

Swinburne J , Ward E , Belchetz P

The possibility of optimal testosterone replacement is hotly debated. Conventional testosterone ester injections give widely fluctuating testosterone levels and may be painful. Testosterone patches currently available in the UK frequently cause intolerable skin irritation and are conspicuously large. The only safe oral preparation testosterone undecanoate rarely provides sustained sufficient circulating testosterone concentrations. Testosterone pellets have been used since sho...

ea0012p96 | Reproduction | SFE2006

Adult survivors of haematological malignancies with premature ovarian failure (POF) secondary to multimodality cancer therapy have normal bone mass

Clay S , Ward E , Cook G , Murray RD

Adult survivors of haematological malignancies are subject to a number of putative insults to the skeleton. Adverse impacts on bone mass include sex-hormone deficiency, radiotherapy, chemotherapy, inadequate nutrition and a generalised catabolic state. We assessed BMD using DXA at the lumbar spine (LS) and femoral neck (FN) in 34 women with POF, defined by secondary amenorrhoea, elevated gonadotropins, and low oestradiol levels. Mean age at diagnosis was 29.7 (range 14–45...

ea0012p97 | Reproduction | SFE2006

The effect of oestrogens on BMD of patients with premature ovarian failure (POF) resulting from multi-modality cancer therapy

Clay S , Ward E , Cook G , Murray RD

The optimal oestrogen dose required to maintain bone mass in young women who develop POF is contentious. We reviewed longitudinal BMD data in 21 women with POF resulting from multi-modality cancer therapy for haematological malignancies. The 21 women were of mean age 30.6 (range 17–45) years at onset of amenorrhoea and weight 64.1+/−11.2 kg. Primary diagnoses were acute myeloid leukaemia (n=12), chronic myeloid leukaemia (n=5), acute lymphocytic leukae...